U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07824674) titled 'The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension' on Aug. 17.
Brief Summary: The goal of this clinical study is to investigate whether the additional intake of sildenafil 20mg on top of standard medical treatment results in a benefit on maximum exercise workload (Wmax) in patients with pulmonary arterial hypertension (PAH).
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Intervention:
DRUG: Dextrose
Administration of Dextrose Candy by mouth as a tablet.
DRUG: Sildenafil 20m...